Stockreport

Vivani Medical obtains Australian approval to begin GLP-1 implant trial [Yahoo! Finance]

Vivani Medical, Inc.  (VANI) 
PDF Committee (HREC) for the initiation of a first-in-human clinical trial in Australia for its glucagon-like peptide 1 (GLP-1) implant, designed for obese and overweight in [Read more]